Articles by Chitra Sethi - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Chitra Sethi

CTI Forms Aequus to Develop Alternative to PEGylation

Mar 22, 2007

Cell Therapeutics, Inc. (CTI, Seattle, WA, www.ctiseattle.com), has formed a new spin-off company, Aequus BioPharma, Inc., to develop a novel process to extend the half-life of proteins.

ADVERTISEMENT

ADVERTISEMENT

Click here